Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.74M Sell
228,300
-263,100
-54% -$9.77M ﹤0.01% 2572
2026
Q1
$18.4M Buy
+491,400
New +$23.3M 0.01% 1621
2025
Q4
Sell
-570,000
Closed -$25.5M 6371
2025
Q3
$25.5M Buy
570,000
+335,000
+143% +$16M 0.01% 1410
2025
Q2
$11.3M Buy
+235,000
New +$10.2M 0.01% 2138
2022
Q2
Sell
-122,597
Closed -$6.37M 7394
2022
Q1
$6.37M Buy
122,597
+84,875
+225% +$4.38M ﹤0.01% 2669
2021
Q4
$2.22M Buy
+37,722
New +$2.16M ﹤0.01% 3680
2019
Q4
Sell
-235,764
Closed -$8.24M 4554
2019
Q3
$8.24M Buy
+235,764
New +$9.07M 0.01% 1418
2017
Q3
Sell
-141,458
Closed -$5.03M 3799
2017
Q2
$5.03M Buy
+141,458
New +$4.78M 0.01% 1501

Other funds holding QGEN

Israel Englander's QGEN Position: Q2 2026 in Review

Israel Englander increased its Qiagen (QGEN) stake by 543% in Q2 2026, buying an estimated $121M and bringing the position to 3,845,605 shares worth $150M. The position accounts for 0.05% of the portfolio, ranked #342.

Israel Englander first reported a position in QGEN in Q1 2017 and has held it in 36 quarters since. The position peaked at $226M in Q4 2020. 332 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • Israel Englander held 3,845,605 shares of Qiagen worth $150M as of Q2 2026.
  • Israel Englander bought 3,247,768 Qiagen shares in Q2 2026, an estimated $121M.
  • Qiagen made up 0.05% of Israel Englander's portfolio in Q2 2026, its #342 holding.
  • Israel Englander first reported a position in Qiagen in Q1 2017 and has held it in 36 quarters since.
  • Israel Englander's Qiagen position peaked at $226M in Q4 2020.
  • 332 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.